ZA976547B - Lipid-binding proteins and their therapeutic and diagnostic use - Google Patents

Lipid-binding proteins and their therapeutic and diagnostic use

Info

Publication number
ZA976547B
ZA976547B ZA976547A ZA976547A ZA976547B ZA 976547 B ZA976547 B ZA 976547B ZA 976547 A ZA976547 A ZA 976547A ZA 976547 A ZA976547 A ZA 976547A ZA 976547 B ZA976547 B ZA 976547B
Authority
ZA
South Africa
Prior art keywords
lipid
therapeutic
binding proteins
diagnostic use
diagnostic
Prior art date
Application number
ZA976547A
Other languages
English (en)
Inventor
Roy Harris
Nicholas David Osborne
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of ZA976547B publication Critical patent/ZA976547B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA976547A 1996-07-23 1997-07-23 Lipid-binding proteins and their therapeutic and diagnostic use ZA976547B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615435.6A GB9615435D0 (en) 1996-07-23 1996-07-23 Spray-dried product and its therapeutic use

Publications (1)

Publication Number Publication Date
ZA976547B true ZA976547B (en) 1998-07-23

Family

ID=10797357

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976547A ZA976547B (en) 1996-07-23 1997-07-23 Lipid-binding proteins and their therapeutic and diagnostic use

Country Status (10)

Country Link
US (2) US6495527B1 (es)
EP (1) EP0918511A2 (es)
JP (1) JP2000514820A (es)
AR (1) AR008072A1 (es)
AU (1) AU720757B2 (es)
CA (1) CA2257524A1 (es)
GB (1) GB9615435D0 (es)
NO (1) NO990303L (es)
WO (1) WO1998003159A2 (es)
ZA (1) ZA976547B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058734A1 (en) * 1999-03-26 2000-10-05 Martek Biosciences Corporation Specific binding assay for docosahexaenoic acid
AU2005318697A1 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
US20080305550A1 (en) * 2005-01-21 2008-12-11 Hollie Huff Targets for Detection of Ischemia
WO2011085070A2 (en) * 2010-01-06 2011-07-14 Virginia Tech Intellectual Properties, Inc. Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
US4720385A (en) * 1983-03-29 1988-01-19 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5725804A (en) * 1991-01-15 1998-03-10 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5981206A (en) * 1992-05-20 1999-11-09 Johnson & Johnson Clinical Diagnostic Systems, Inc. Dry analytical element and method for the detection of prostatic acid phosphatase
US5567415A (en) * 1993-05-12 1996-10-22 The Board Of Regents Of The University Of Nebraska Ultrasound contrast agents and methods for their manufacture and use
KR970705979A (ko) 1994-09-29 1997-11-03 디 히스 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles)
CZ183797A3 (en) * 1994-12-16 1997-11-12 Andaris Ltd Cross-linked micro-particles and their use as a therapeutic carrier
DE19651886A1 (de) * 1996-12-13 1998-06-18 Merck Patent Gmbh Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
US6352835B1 (en) * 1998-11-17 2002-03-05 Kyoto Daiichi Kagaku Co. Ltd. Method of measuring substance in sample using a redox reaction

Also Published As

Publication number Publication date
AU3628697A (en) 1998-02-10
EP0918511A2 (en) 1999-06-02
JP2000514820A (ja) 2000-11-07
AR008072A1 (es) 1999-12-09
AU720757B2 (en) 2000-06-08
NO990303L (no) 1999-03-22
CA2257524A1 (en) 1998-01-29
NO990303D0 (no) 1999-01-22
WO1998003159A2 (en) 1998-01-29
US6495527B1 (en) 2002-12-17
WO1998003159A3 (en) 1998-05-07
US20030170177A1 (en) 2003-09-11
GB9615435D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
AU7383298A (en) Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
AU4172597A (en) Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
AU1886197A (en) Quinolones and their therapeutic use
EP0831793A4 (en) PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
GB9414157D0 (en) Medical use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
GB9514816D0 (en) Substances and their medical use
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
AU3116697A (en) Human interleukin-1j and antagonists thereof
GB9712707D0 (en) Medical device and use thereof
GB9616504D0 (en) Therapeutic product and its use
AUPO338496A0 (en) Therapeutic and diagnostic agents
GB9609521D0 (en) Substances and their therapeutic use
GB9621314D0 (en) Substances and their therapeutic use
ZA9710000B (en) Quinolines and their therapeutic use
AUPO511797A0 (en) Therapeutic and diagnostic agents-II
GB9611898D0 (en) Quinolones and their therapeutic use
ZA958760B (en) Tropane-derivatives their preparation and use
ZA951726B (en) Carbamoylcarboxamides their preparation and their use
AUPP017497A0 (en) Therapeutic and diagnostic agents
GB9600849D0 (en) Diagnostic method and use